JPMorgan Healthcare Leaders ETF(JDOC)

upturn advisory logo
EXPLORE ADVISORIES AND THEIR HISTORY
QUALITY SIGNAL RECENCY
3-STAR RATING
STRONG BUY
BUY for 17 days
PROFIT SINCE LAST BUY
+4.85% ▲
LAST CLOSE
$67.25
11/13/2026
(24-hour delay)

Advisory History & Simulated Performance *

*as per simulation (see disclosures)
  • ALL
  • 1Y
  • 1M
  • 1W
  • BUY Advisory
  • SELL Advisory (Profit)
  • SELL Advisory (Loss)
  • Profit
  • Loss
  • PASS (Skip)
Upturn Stock price based on last close iconStock price based on last close
Simulated performance—not actual client returns. Excludes advisory subscription fees, trading commissions, and taxes, which would reduce returns. Results depend on calculation assumptions and do not guarantee future outcomes. See Disclosures for full methodology, assumptions, and limitations.

Advisory Performance History (Simulated)Advisory Performance History info

Simulated performance—not actual client returns. Excludes advisory subscription fees, trading commissions, and taxes, which would reduce returns. Results depend on calculation assumptions and do not guarantee future outcomes. See Disclosures for full methodology, assumptions, and limitations.

Upturn Advisory & Investor View for JDOC

11/13/2026: JDOC (3-star) is a STRONG-BUY. BUY for 17 days. Simulated Profits (4.85%). Updated daily EoD!

JPMorgan Healthcare Leaders ETF (JDOC) is an actively managed fund that provides exposure to a curated portfolio of high-quality, market-leading healthcare companies globally. By focusing on firms with strong competitive moats and financial stability, it aims for long-term capital appreciation, differentiating itself from the massive, passive healthcare index funds. Its main strengths include professional, research-driven stock selection and a quality bias, making it a suitable tool for investors who believe active managers can identify outperformers in the complex healthcare landscape. Key risks include exposure to regulatory changes, sector-specific volatility, and the higher costs associated with active management. It is best suited for long-term growth-oriented investors who want exposure to sector leaders but prefer an active hand to navigate the industry's unique risks and opportunities.

How to Read the Upturn Advisory

The Upturn Star Rating and the current BUY, SELL, or PASS advisory are generated by Upturn’s AI advisory engine based on proprietary signal analysis, price behavior, advisory history, and historical signal performance.

ETF holdings, costs, diversification, valuation, risks, and market conditions provide supporting context about the fund.

Investor Fit

Investor styleFitWhy
Growth investorStrong fitThe fund targets companies with strong innovation and market leadership that drive long-term capital appreciation.
Momentum investorMixed fitWhile the fund holds strong leaders, it is not specifically designed to capture short-term technical momentum, so success is conditional on positive sector trends.
Value investorMixed fitThe fund focuses on quality and leadership rather than strictly identifying undervalued stocks, though it avoids overpaying for growth.
Dividend/Income investorWeak fitJDOC prioritizes capital growth over dividend yield, making it less suitable for those primarily seeking income.
Low-risk investorWeak fitThe concentrated nature of the fund and healthcare sector volatility result in risk levels unsuitable for ultra-conservative investors.

Investor Profile

Ideal Investor Profile

The ideal investor is an individual seeking long-term growth from the healthcare sector who prefers professional, active management over passive index exposure.

Suitability

JDOC is best for long-term investors willing to pay a premium for active stock selection and potential for alpha generation.

Risk Profile

Risk factorLevelWhy it matters
VolatilityMedium / highHealthcare stocks can experience sharp movements due to clinical trial results and regulatory announcements.
Market riskMediumThe fund is subject to general equity market downturns which can impact all sectors simultaneously.
ConcentrationMedium / highA focused portfolio means the fund is more susceptible to the performance of individual stock picks.
Tracking/expenseMediumThe active management fee is higher than passive index funds, requiring outperformance to justify the cost.
LiquidityMediumWhile underlying stocks are liquid, the ETF itself may have lower trading volume than massive sector trackers.
Business/sector qualityLowThe focus on large-cap leaders generally mitigates the risk of business failure compared to small-cap biotech exposure.

Sector & Industry Intelligence

This fund is not assigned to one sector.

Risk Analysis

Volatility

JDOC exhibits moderate volatility characteristic of the healthcare sector, influenced by scientific and regulatory outcomes.

Market Risk

The fund faces risks related to healthcare-specific policy, global macro-economic shifts, and general equity market downturns.

What the ETF Owns

Exposure TypeExposureWeight (%)Retail Investor Read
SectorPharmaceuticals & Biotechnology55This exposure provides the core growth engine of the fund through drug development and life sciences innovation.
SectorHealthcare Equipment & Supplies25These holdings capture stable demand for medical technology and essential healthcare infrastructure.
SectorManaged Healthcare & Services15This segment provides defensive stability and consistent cash flow to the overall portfolio.
Cash/collateralCash and Cash Equivalents5Maintained for liquidity requirements and tactical management opportunities.

Price Behavior

Strong Uptrend
PRICE PATH

Strong Uptrend

The stock has maintained a strong upward price trend across the last three quarters.

Very Smooth
PRICE STABILITY

Very Smooth

The stock has followed a highly orderly price path with minimal short-term disruption.

Analysis of Past Performance

Type ETF
Historic Profit 29.01%
Avg. Invested days 64
Today’s Advisory Strong Buy
Upturn Advisory Rating upturn star rating icon
Upturn Advisory Performance Upturn Advisory Performance icon 4.0
ETF Returns Performance Upturn Returns Performance icon 4.0
Upturn Profits based on simulation icon Profits based on simulation
Upturn last close icon Last Close 11/13/2026
Form CRS provides a relationship summary of our automated advisory services, flat subscription fees, and conflicts of interest. Form ADV Part 2A brochure contains complete details on services, billing, and disclosures. If any summary differs from our current regulatory filings, the filed Form ADV controls.